News Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration Staff September 11, 2023 Iframe sync Post navigation Previous: Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in BostonNext: Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 More Stories Clinical Trial COVID-19 News Vaccine Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods Staff December 14, 2025 Cancer Clinical Trial News Pharmaceutical InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial Staff December 14, 2025 Healthcare News Pharmaceutical President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way Staff December 13, 2025
